Greater access to antibiotics is essential for curbing drug resistance

  14 April 2022

As the latest wave of Covid-19 wanes, the hidden pandemic of antibiotic-resistant infections is becoming apparent. Recent estimates indicate that about 1.3mn deaths each year are caused by drug-resistant infections โ€” more than the toll from any infectious disease, apart from Covid-19 and tuberculosis. These deaths reflect a growing resistance, and lack of access, to affordable and effective antibiotics, especially for people living in low- and middle-income countries. There is now growing โ€” if still grossly inadequate โ€” attention being paid to preventing resistance and developing new drugs. But the international response has largely ignored the matter of access to them, to the detriment of immediate health needs and the long-term effort to curb drug-resistant infections.

Further reading: Financial Times
Author(s): Ramanan Laxminarayan
Effective Surveillance  
Back

OUR UNDERWRITERS

Unrestricted financial support by:

LifeArc

Antimicrobial Resistance Fighter Coalition

Bangalore Bioinnovation Centre

INTERNATIONAL FEDERATION PHARMACEUTICAL MANUFACTURERS & ASSOCIATIONS





AMR NEWS

Every two weeks in your inbox

Because there should be one newsletter that brings together all One Health news related to antimicrobial resistance: AMR NEWS!

Subscribe

What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!

Keep me informed